NASDAQ: MYGNMyriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?
Insider buying vs selling
Have Myriad Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dale Muzzey | Chief Scientific Officer | 2026-01-01 | 418 | $6.15 | $2.57kSell |
| Benjamin Richard Wheeler | Chief Financial Officer | 2025-12-25 | 21 | $6.55 | $137.55Sell |
| Samraat S. Raha | President and CEO | 2025-12-11 | 29,634 | $7.30 | $216.33kSell |
| Benjamin Richard Wheeler | Chief Financial Officer | 2025-09-21 | 2,559 | $7.77 | $19.88kSell |
| Natalie Munk | Chief Accounting Officer | 2025-09-21 | 962 | $7.77 | $7.47kSell |
| Margaret Ancona | EVP Strategy Transformation | 2025-09-21 | 958 | $7.77 | $7.44kSell |
| Mark Verratti | Chief Operating Officer | 2025-09-21 | 1,085 | $7.77 | $8.43kSell |
| Jennifer Lynne Fox | Chief Legal Officer | 2025-09-03 | 4,435 | $6.80 | $30.16kSell |
| Samraat S. Raha | President and CEO | 2025-05-31 | 1,498 | $3.56 | $5.34kBuy |
| Dale Muzzey | Chief Scientific Officer | 2025-04-14 | 942 | $8.08 | $7.61kSell |
MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYGN insiders and whales buy or sell their stock.
MYGN Shareholders
What type of owners hold Myriad Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 16.42% | 15,303,850 | $65.65M | Institution |
| Vanguard Group Inc | 8.82% | 8,225,371 | $35.29M | Institution |
| Millennium Management LLC | 7.19% | 6,700,158 | $28.74M | Institution |
| State Street Corp | 6.40% | 5,966,567 | $25.60M | Institution |
| Glenview Capital Management LLC | 4.92% | 4,587,407 | $19.68M | Institution |
| D E Shaw Co Inc | 4.83% | 4,505,193 | $19.33M | Institution |
| Morgan Stanley | 3.87% | 3,607,789 | $15.48M | Institution |
| Jacobs Levy Equity Management Inc | 2.44% | 2,270,378 | $9.74M | Institution |
| Geode Capital Management LLC | 2.39% | 2,231,292 | $9.57M | Institution |
| Goldman Sachs Group Inc | 2.32% | 2,160,282 | $9.27M | Institution |
MYGN vs Diagnostic & Research Stocks
Myriad Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.